Good feature in the April edition of Nature Biotechnology. Penned by Jeff Fox, the atrticle is titled, "Mixed Messages from Washington."
How unusual!
Good parts about FOBs and FDA funding as well as other excellent bits.
One snippet, "PDUFA negotiations provide an excellent opportunity to lay it on the line honestly and explain to Congress why FDA needs to be funded robustly. PDUFA, "gave industry better predictability and FDA more money, but it swerved off that path and promises were not kept. Industry now wants to get back to those promises."
Who said that? For the answer to that question and many others, see the complete article here.
Blurry Vision
Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.
